Tag Archive
Phase II clinical trial results of Doxorubicin Transdrug announced (News-Medical-Net)
BioAlliance Pharma SA, a company dedicated to the treatment and supportive care of cancer and AIDS patients, today announces positive survival data in its phase II clinical trial with doxorubicin Transdrug® in patients with advanced hepatocellular carcinoma (primary liver cancer). (read here…) Related items Doxorubicin Transdrug(R): Significant Increased Survival Rate In Patients With Advanced Hepatocellular Carcinoma …... »
Doxorubicin Transdrug®: Significant increased survival rate in patients with advanced hepatocellular carcinoma treated … (Business Wire via Yahoo! Finance)
PARIS—-BioAlliance Pharma SA , a company dedicated to the treatment and supportive care of cancer and AIDS patients, today announces positive survival data in its phase II clinical trial with doxorubicin Transdrug® in patients with advanced hepatocellular carcinoma . (read here…) Related items Phase II clinical trial results of Doxorubicin Transdrug announced (News-Medical-Net) Doxorubicin Transdrug(R): Significant Increased Survival... »
PES College organizes international conference on ‘Status of pharmaceutical sciences’ (PharmaBiz)
Pharma industry and the research labs should train fresh candidates with structured programmes and facilitate research with latest updates. The future of pharmaceutical sciences is stem cell research, nanotechnology, drug delivery, process analytical technology (PAT) and green chemistry. (read the story…) Related items Nanotechnology-Enabled Sensors To Be Discussed At Conference (Medical News Today) New insight in nerve cell... »
